UK markets closed

AnaptysBio, Inc. (0HFQ.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
22.32+0.77 (+3.57%)
At close: 04:27PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.27
52-week change 319.00%
S&P500 52-week change 327.86%
52-week high 327.27
52-week low 313.80
50-day moving average 321.59
200-day moving average 321.15

Share statistics

Avg vol (3-month) 3169
Avg vol (10-day) 3186
Shares outstanding 526.75M
Implied shares outstanding 6N/A
Float 814.73M
% held by insiders 10.40%
% held by institutions 1113.56%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-386.41%

Management effectiveness

Return on assets (ttm)-18.47%
Return on equity (ttm)-93.44%

Income statement

Revenue (ttm)17.16M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)32.30%
Gross profit (ttm)N/A
EBITDA -156.42M
Net income avi to common (ttm)-163.62M
Diluted EPS (ttm)-2.76
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)390.9M
Total cash per share (mrq)14.61
Total debt (mrq)328.62M
Total debt/equity (mrq)373.00%
Current ratio (mrq)10.87
Book value per share (mrq)3.31

Cash flow statement

Operating cash flow (ttm)-120.8M
Levered free cash flow (ttm)-73.42M